相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials
Kang Sim et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Joshua D. Rosenblat et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Antidepressant Nonadherence in Routine Clinical Settings Determined From Discarded Blood Samples
Ashlee M. Roberson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
F. Hieronymus et al.
MOLECULAR PSYCHIATRY (2016)
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Trisha Suppes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly
Glenda M. MacQueen et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods
Raymond W. Lam et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
Sagar V. Parikh et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments
Roumen V. Milev et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study
George I. Papakostas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Bruce A. Arnow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis
Klaus Linde et al.
ANNALS OF FAMILY MEDICINE (2015)
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
Hai-Yin Jiang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
Ai Leng Khoo et al.
CNS DRUGS (2015)
Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis
Britta Galling et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis
Yiyun Liu et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
The use of ketamine as an antidepressant: a systematic review and meta-analysis
Caoimhe M. Coyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
Xinyu Zhou et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
How much do we know about the functional effectiveness of interventions for depression? A systematic review
Kaloyan Kamenov et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Summary of Findings From the FDA Regulatory Science Forum on Measuring Sexual Dysfunction in Depression Trials
Phillip D. Kronstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis
Xinyu Zhou et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression
Ross J. Baldessarini et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression A Meta-Analysis
Siegfried Alberti et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
Sheldon Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2015)
Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
Changsu Han et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: Efficacy and tolerability
Alexander McGirr et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
Chi-Un Pae et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
Giovanni A. Fava et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
Stuart A. Montgomery et al.
CNS SPECTRUMS (2015)
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
Le-Ben Wan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy
David J. Hellerstein et al.
CORE EVIDENCE (2015)
Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis
Rebecca Anglin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
X. J. Wen et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis
Barbara Nussbaumer et al.
CNS DRUGS (2014)
QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review
Mehrul Hasnain et al.
CNS DRUGS (2014)
Role of Lithium Augmentation in the Management of Major Depressive Disorder
Michael Bauer et al.
CNS DRUGS (2014)
Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions
Paul A. Kudlow et al.
CNS DRUGS (2014)
The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Gianluca Serafini et al.
CURRENT NEUROPHARMACOLOGY (2014)
EFFICACY AND ACCEPTABILITY OF ACUTE TREATMENTS FOR PERSISTENT DEPRESSIVE DISORDER: A NETWORK META-ANALYSIS
Levente Kriston et al.
DEPRESSION AND ANXIETY (2014)
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
Ursula Reichenpfader et al.
DRUG SAFETY (2014)
The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study
J. A. Quiroz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Pramipexole augmentation in treatment-resistant major depressive disorder
Chi-Un Pae
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
CAC Coupland et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
Roger S. McIntyre et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression
J. Craig Nelson et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A Review of the Use of Stimulants and Stimulant Alternatives in Treating Bipolar Depression and Major Depressive Disorder
Stephanie A. Corp et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration
Silvana Borges et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Combination antidepressant therapy for major depressive disorder: Speed and probability of remission
Jonathan W. Stewart et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder
Manisha Madhoo et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder
E. J. Brandl et al.
PHARMACOGENOMICS JOURNAL (2014)
Pharmacogenomic Testing for Neuropsychiatric Drugs: Current Status of Drug Labeling, Guidelines for Using Genetic Information, and Test Options
Katarzyna Drozda et al.
PHARMACOTHERAPY (2014)
Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
Kyoung-Sae Na et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression - A systematic review
Bernhard T. Baune et al.
PSYCHIATRY RESEARCH (2014)
Ketamine administration in depressive disorders: a systematic review and meta-analysis
Guillaume Fond et al.
PSYCHOPHARMACOLOGY (2014)
The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives
Andre F. Carvalho et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2014)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Lakshmi N. Yatham et al.
BIPOLAR DISORDERS (2013)
Clinically Significant Drug Interactions with Atypical Antipsychotics
William Klugh Kennedy et al.
CNS DRUGS (2013)
Rational Use of Generic Psychotropic Drugs
Maren Carbon et al.
CNS DRUGS (2013)
Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression
Tanja Veselinovic et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data
Bernardo Dell'Osso et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
A review of current evidence for vilazodone in major depressive disorder
Sheng-Min Wang et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2013)
Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis
A. von Wolff et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Repeated S-Ketamine Infusions in Therapy Resistant Depression: A Case Series
Felix Segmiller et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Modafinil Augmentation Therapy in Unipolar and Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander J. Goss et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram
Madhukar H. Trivedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder
Cristina Cusin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Relationship between use of antidepressants and risk of fractures: a meta-analysis
V. Rabenda et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
Glen I. Spielmans et al.
PLOS MEDICINE (2013)
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved
Thibault Renoir
FRONTIERS IN PHARMACOLOGY (2013)
Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
W. Victor R. Vieweg et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Suicidal Thoughts and Behavior With Antidepressant Treatment Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine
Robert D. Gibbons et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings
Fionn E. O'Brien et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Clinically Significant Drug Interactions with Newer Antidepressants
Edoardo Spina et al.
CNS DRUGS (2012)
COMPARATIVE EFFECTIVENESS OF SECOND-GENERATION ANTIDEPRESSANTS FOR ACCOMPANYING ANXIETY, INSOMNIA, AND PAIN IN DEPRESSED PATIENTS: A SYSTEMATIC REVIEW
Kylie J. Thaler et al.
DEPRESSION AND ANXIETY (2012)
Emerging drugs for major depressive disorder
Kevin Ryan Connolly et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
Cornelius Katona et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis
Chun-Sick Eom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Combination of Antidepressants in the Treatment of Major Depressive Disorder A Systematic Review and Meta-Analysis
Fabio Lopes Rocha et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Treating Depression After Initial Treatment Failure Directly Comparing Switch and Augmenting Strategies in STAR*D
Bradley N. Gaynes et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Early Switch Strategy in Patients With Major Depressive Disorder A Double-Blind, Randomized Study
Irene Romera et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Lobna Ibrahim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
Jean-Philippe Boulenger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Withdrawal of Generic Budeprion for Nonbioequivalence
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies
Q. Wu et al.
OSTEOPOROSIS INTERNATIONAL (2012)
A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State
Ashwin Patkar et al.
PLOS ONE (2012)
Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model
Joakim Ramsberg et al.
PLOS ONE (2012)
Management of Treatment-Resistant Depression
Gabor I. Keitner et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis
Gerald Gartlehner et al.
ANNALS OF INTERNAL MEDICINE (2011)
Meta-Analysis of Efficacy and Treatment-Emergent Suicidality in Adults by Psychiatric Indication and Age Subgroup Following Initiation of Paroxetine Therapy: A Complete Set of Randomized Placebo-Controlled Trials
David J. Carpenter et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Vilazodone: Clinical Basis for the US Food and Drug Administration's Approval of a New Antidepressant
Thomas P. Laughren et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study
Mohammad R. Safarinejad
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: A randomized open-label trial
Shinichiro Nakajima et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Genes, Environment, and Individual Differences in Responding to Treatment for Depression
Rudolf Uher
HARVARD REVIEW OF PSYCHIATRY (2011)
Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
Pierre Blier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Do atypical features affect outcome in depressed outpatients treated with citalopram?
Jonathan W. Stewart et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release
Madhukar H. Trivedi et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
J. Craig Nelson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
Rudolf Uher et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
Corrado Barbui et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation
Pierre Blier et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. Ill. Pharmacotherapy
Raymond W. Lam et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults Introduction
Sidney H. Kennedy et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression
Madhukar H. Trivedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
Marc Stone et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The importance of functional impairment to mental health outcomes: A case for reassessing our goals in depression treatment research
Patrick E. McKnight et al.
CLINICAL PSYCHOLOGY REVIEW (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Treatment of SSRI-resistant depression: A meta-analysis comparing within-versus across-class switches
George I. Papakostas et al.
BIOLOGICAL PSYCHIATRY (2008)
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report
William S. Gilmer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report
Patrick J. McGrath et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: Results of a double-blind, randomized, placebo-controlled trial
Arun V. Ravindran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Evaluation of networks of randomized trials
Georgia Salanti et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors
Rena Cooper-Kazaz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care
Madhukar H. Trivedi et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods
Marcelo T. Berlim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2007)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy
JA Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2005)
分享论文
